HC Wainwright & Co. Reiterates Indaptus Therapeutics (INDP) Buy Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on August 15, 2023, HC Wainwright & Co. reiterated coverage of Indaptus Therapeutics (NASDAQ:INDP) with a Buy recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-458984107-4b61a6c8b7614499abf70b4b3f37b200.jpg "<div>Who Are ExxonMobil's Main Competitors?</div>")
:max_bytes(150000):strip_icc():format(jpeg)/womanconsideringcdinvestment-e16f8c13aa464f9a849b7cf2ef5d3f9e.jpg "CD Rates Could Change in 2025. Will They Still Be a Good Buy?")
:max_bytes(150000):strip_icc():format(jpeg)/220425_3858-d06c53ed863545eca0498319c94f1f94.jpg "Why This Gorgeous Beach Town is The Perfect Place for Your Retirement")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1584911699-849dc1e0d3644bac9c54826af8d8fdad.jpg "What Types of Shares Can Public Limited Companies Issue?")